A detailed history of Leeward Financial Partners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Leeward Financial Partners, LLC holds 8,686 shares of VRTX stock, worth $4.12 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares
8,686
Previous 8,559 1.48%
Holding current value
$4.12 Million
Previous $3.48 Million 4.25%
% of portfolio
1.54%
Previous 1.7%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$407.69 - $446.08 $51,776 - $56,652
127 Added 1.48%
8,686 $3.63 Million
Q4 2023

Jan 26, 2024

SELL
$343.0 - $410.68 $117,649 - $140,863
-343 Reduced 3.85%
8,559 $3.48 Million
Q3 2023

Oct 31, 2023

BUY
$338.18 - $362.46 $464,997 - $498,382
1,375 Added 18.27%
8,902 $3.1 Million
Q2 2023

Aug 07, 2023

BUY
$314.42 - $351.91 $2.37 Million - $2.65 Million
7,527 New
7,527 $2.65 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $122B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Leeward Financial Partners, LLC Portfolio

Follow Leeward Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leeward Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Leeward Financial Partners, LLC with notifications on news.